- $503.56m
- $372.94m
- $1.66m
Annual balance sheet for Shattuck Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 39.1 | 335 | 269 | 161 | 131 |
| Prepaid Expenses | |||||
| Total Current Assets | 42.4 | 346 | 288 | 185 | 143 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.44 | 3 | 9.94 | 20.3 | 16.1 |
| Other Long Term Assets | |||||
| Total Assets | 45 | 349 | 299 | 205 | 160 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 20 | 16.8 | 24.6 | 25 | 11.5 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 30.5 | 39.1 | 26.8 | 29.2 | 14.9 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 14.5 | 310 | 272 | 176 | 145 |
| Total Liabilities & Shareholders' Equity | 45 | 349 | 299 | 205 | 160 |
| Total Common Shares Outstanding |